Multiple Sclerosis (MS) Drug Market

RECENT NEWS
GenEng News  Oct 1  Comment 
The demand for peptides as active pharmaceutical ingredients (APIs) is continuously increasing because they are highly active, highly specific, and metabolically favorable substances. Peptides perform diverse physiological functions, and thus are...
GenEng News  Sep 30  Comment 
Patients with multiple sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to an article (“Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A...
newratings.com  Sep 24  Comment 
HAMBURG (dpa-AFX) - Evotec AG (EVTCY.PK, EVOTF.PK) a German drug discovery and development company, announced Wednesday that it has entered into three novel research projects for the treatment of Multiple Sclerosis or MS supported by research...
MedPage Today  Sep 18  Comment 
BOSTON (MedPage Today) -- Multiple sclerosis patients with larger intracranial volumes -- a measure of their lifetime maximal brain size -- scored better on cognition and physical function tests than those with smaller skull sizes.
MedPage Today  Sep 17  Comment 
BOSTON (MedPage Today) -- An objectively measured sign of spasticity in multiple sclerosis patients was relieved with Sativex, the oromucosal cannabinoid spray, in a small randomized trial reported here.
MedPage Today  Sep 17  Comment 
BOSTON (MedPage Today) -- Pressure sensitive walkways and motion tracking devices provided reliable quantitative measures of ambulation in multiple sclerosis patients, researchers said here.
MedPage Today  Sep 16  Comment 
BOSTON (MedPage Today) -- Women using combined oral contraceptives containing norethindrone or levonorgestrel were substantially more likely to develop multiple sclerosis than those not on "The Pill."
MedPage Today  Sep 15  Comment 
BOSTON (MedPage Today) -- Dietary patterns in women did not appear to influence their risk of developing multiple sclerosis, according to a large study with 2 decades of follow-up.
MedPage Today  Sep 14  Comment 
BOSTON (MedPage Today) -- A biologic drug targeting the granulocyte-macrophage colony stimulating factor was safe and showed hints of activity against brain lesions in multiple sclerosis patients in a phase I trial.
MedPage Today  Sep 14  Comment 
BOSTON (MedPage Today) -- An investigational oral drug for multiple sclerosis with the same mechanism as the approved product fingolimod (Gilenya) was highly effective in a phase II trial with seemingly fewer effects on cardiac function than the...




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki